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Background: The adherence to the prescribed oxygen therapy is difficult to obtain
for patients on long-term oxygen therapy (LTOT). There is little information on the
modalities of oxygen utilisation for patients on LTOTwho are using liquid oxygen in
real life.
Study objective: Evaluation of the behaviour and the knowledge regarding LTOT in a
large group of patients mainly using liquid oxygen.
Design and setting: Questionnaire administered to consecutive outpatients on
domiciliary LTOT for at least 6 months referring to one of 20 clinics throughout Italy.
Blinded to this result, the physician who cared for the patient completed another
questionnaire.
Results: We evaluated 1504 patients (mean age 71.6 years; males 64%; 74% suffering
from COPD). Most respondents (93%) used liquid oxygen with mobile device. Fifteen
per cent of patients had a prescribed length of oxygen therapy less than 15 h/day;
21% reported to practice oxygen for less than 15 h/day. Patients reported usingElsevier Ltd. All rights reserved.
7586760; fax: +390577586196.
.toscana.it (A.S. Melani).
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k ¼ 0:80) during exercise (P ¼ 0:002, k ¼ 0:72) and at night (P ¼ 0:0036, k ¼ 0:77).
There was no difference between the flow prescribed by the physician and that
known and practised by the patient at rest or during sleep; during exercise the flow
reported by patients was lower than that prescribed by the physician. Patients used
in the night but not at rest or during exercise, a lower level of oxygen flow than what
they knew had been prescribed. Fifty-five per cent of patients received indications
to modify the oxygen flow in the various situations of life. Liquid oxygen was almost
always useful to decrease breathlessness. Most (84%) patients possessed a mobile
device, but only 40% declared they used it daily, ‘shame’ being indicated as the
principal barrier. On the physicians’ side, we found that the criteria used in
prescribing did not always correspond to evidence-based recommendations.
Conclusion: The widespread use of liquid oxygen did not automatically assure
optimal adherence to the prescribed treatment as regards times and modality of
oxygen use. A better education of patients, relatives, and the general public, as well
as increased self-assessment on the part of health caregivers would improve the
practice of LTOT in Italy.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Long-term oxygen therapy (LTOT) has been widely
practised in Italy as well as in other western
countries for many years, on the grounds of its
proven demonstrations of efficacy acknowledged by
the scientific community.1,2 Recently its value has
been confirmed in the joint statement of leading
international Scientific Societies of Respiratory
Medicine.3 LTOT is effective on survival if the
supplements of oxygen useful to maintain the
arterial oxygen tension (PaO2) above 8 kPa are
administered for at least 15 h/day.1,2 LTOT is very
compelling for patients. Since its first demonstra-
tion of efficacy, the adherence to the prescribed
oxygen therapy resulted a problem for patients on
LTOT.1 The largest information on the adherence to
LTOT comes from countries,4–7 where most patients
were using gaseous oxygen and concentrators. As
many patients on domiciliary LTOT go outside the
house, the use of liquid oxygen, ideally suited for
the easy filling of portable systems at home, could
possibly improve compliance to the prescribed
treatment.8,9 Effectively, some studies have shown
that selected patients use liquid oxygen longer than
gaseous oxygen.9,10 However, due to its extensive
cost, the generalised diffusion of liquid oxygen
remains uncommon, although increasing, in most
western countries.
The peculiarity of the Italian situation is that
almost everywhere exclusively liquid oxygen is
used, while gaseous oxygen is reserved only for
the terminally ill or in temporary situations as
dyspnea relief in acute bronchitis riexacerbations.
Concentrators are rarely used, mainly because the
regulations until very recently made such a pre-scription very complicated under the National
Health Service.
The primary aim of this survey was the evaluation
of the behaviour and the knowledge about oxygen
therapy in a large group of patients on LTOT, mainly
using liquid oxygen. Other aims were to evaluate
how well the information supplied by prescribing
physicians as regards times and modality of oxygen
use corresponds to what patients say they have
been told. How well LTOT prescriptions correspond
to international criteria. How well founded the
impressions of many pulmonologists are on the
need to give patients on LTOT more ample and
detailed explanations in order to improve their
understanding and compliance to treatment.Material and methods
This survey was an open, multicentre, observa-
tional study promoted by the Italian Association of
Hospital Pulmonologists (AIPO) Educational Group.
Twenty chest clinics throughout Italy (listed below)
took part in the study, carried out between April
2002 and March 2003. A questionnaire was con-
secutively administered to all outpatients, report-
ing to one of the clinics, who had been on
domiciliary LTOT for at least 6 months. The
participating centres were distributed throughout
the whole national territory and included both
urban and rural areas; hence they can be consid-
ered as representative of the Italian national
context. In order to standardise the design of the
survey, periodic meetings were held with and
phone contacts made to all participants before
and during the study period. The questionnaire (see
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Table 1 Some characteristics of enrolled patients.
Respiratory diagnosis Number (%) Mean (7SD)
age
% Male Smoking status (current
smokers/never smokers/
former smokers, %)
FEV1 (7SD) %
pred
COPD 1041 (74) 7279 66 8/23/69 46716
Interstitial lung disease 169 (12) 70710 57 1/50/49 55718
Fibrosis post-TB 142 (10) 7378 54 3/48/49 41714
Bronchiectasis 89 (6) 70711 62 1/44/55 43713
Cancer 50 (4) 71710 82 6/17/77 62713
Kyphoscoliosis 43 (4) 66711 30 2/80/18 50718
Obesity 62 (5) 63716 29 0/75/25 55715
Obstructive sleep apnoea 44 (4) 62713 45 5/70/25 55716
Neuromuscular disease 8 (0.1) 46729 63 0/88/12 5478
The total number of patients according to the respiratory diagnosis is greater than the total number of enrolled patients
because it was possible for the doctor to fill in more than 1 answer (for example, COPD and bronchiectasis).
Long-term oxygen therapy in chronic respiratory failure 797reproduction) was printed, computer-scannable
and preliminarily prepared by the AIPO Educational
Group members. The questionnaire consisted of 26
and 33 closed-type questions, written on the back
and front of a single sheet of paper, to be
completed, respectively, by the physician and
patient. The responses of the patient were blinded
to the physician and vice versa. Its comprehensi-
bility and reliability had also been tested during a
preliminary phase by a group of patients that were
not enrolled in the present study. Informed consent
was obtained from the patients at the moment of
collecting the data (Appendix).
Unless stated otherwise, results are presented as
absolute numbers, or in percentage, or as mean7SD.
Univariate statistical analysis of categorical variables
was performed using w2 test, and logistic regression
was used when appropriate to adjust for relevant
confounders. Analysis of continuous variables was
performed using Student’s t test or ANOVA as app-
ropriate. Comparison between patient- and doctor-
reported use of oxygen was performed using the
non-parametric rank sum test, while the agreement
between the two sources was evaluated using
Cohen’s k coefficient. All P values were calculated
by two-tailed distribution, and values equal or lower
than 0.05 for a two-tailed distribution were con-
sidered statistically significant. All the analyses were
performed using the statistical package Stata 8 on
a PC-compatible personal computer (Stata corp,
College Station, TX).Results
We collected 1504 questionnaires (mean number of
questionnaires per centre, 75). No patient on LTOTwho satisfied the inclusion criteria did refuse to
participate in the study. Ninety-hundred and nine
(60%) questionnaires were filled in by males, 596
(40%) by females; mean (7SD) age of partici-
pants was 71.6 (710 SD) years. One thousand
three hundred and forty-one patients (93% of
respondents) used liquid oxygen, 82 (6%) a con-
centrator and 21 (1%) gaseous oxygen. Patients
characteristics are shown in Table 1. Ninety per
cent of patients were already registered at
the Centre in which they were recruited; 10%
were first time patients at the recruiting
centre; this subset had therefore received their
LTOT prescription elsewhere. The physician
who first prescribed LTOT was a respiratory specia-
list in 94% of cases. The first prescription of
LTOT was made less than 1 year preceding
the survey in 18% of cases, between 1 and 2 years
in 21%, between 2 and 5 years in 38%, more
than 5 years in 23%. The educational level of
patients who responded to the question (data
missing in 9% of questionnaires) was: no formal
education in 8.7%, primary education in 60.2%,
lower middle school in 17.3%, secondary education
in 10.5%, and university education in 3.3%. All
patients (except nine subjects) were retired.
Concerning the smoking habits (Table 1), 6.5% of
patients responded that they still smoked despite
the disease and oxygen therapy. The highest
percentage of current smokers was in the COPD
group.
As Table 2 shows, 206 patients on LTOT also used
a ventilator, of which 17% a volumetric device, 58%
Bi-level, 18% CPAP, 7% not specified. Patients
declared that they used the ventilator everyday in
99% of cases: 11% said they used the ventilator for
less than 5 h/day, 56% for 6–9 h/day, 33% for more
than 9 h.
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therapy reported by the physician (Tables 3 and
4), the indication was to practice less than 15 h/day
in a significant percentage of cases, independently
of the respiratory diagnosis. The indication to
modify the oxygen flow in the different situations
of everyday life was reported by the physician in
45% of cases. A detailed list of the oxygen flowsTable 2 Number of patients on LTOT who also
used a ventilator according to their diagnosis.
Main diagnosis No
Kyphoscoliosis 26
Bronchiectasis 6
Obesity 44
Obstructive sleep apnoea 32
Neuromuscular disease 7
COPD 127
Interstitial lung disease 5
Fibrosis post-TB 23
Not specified 3
The total number of patients according to the
respiratory diagnosis is greater than the total number of
ventilated patients because it was possible for the doctor
to fill in more than 1 answer.
Table 3 Prescribed daily length of oxygen ther-
apy reported by the physician at the last follow-up
visit.
Hours/day No of patients (%)
Up to 9 38 (3%)
9–14 172 (12%)
15–20 683 (50%)
21–24 496 (35%)
Table 4 Some details of LTOT prescription reported by t
Respiratory diagnosis Prescription o15 h/day,
number of patients (%)
COPD 109 (11)
Interstitial lung disease 18 (11)
Fibrosis post-TB 14 (11)
Bronchiectasis 7 (9)
Cancer 12 (25)
Kyphoscoliosis 6 (8)
Obesity 15 (22)
Obstructive sleep apnoea 13 (31)
Neuromuscular disease 1 (12)prescribed by the physician in the various situations
of everyday life is reported in Table 5. The most
common indication was to increase the oxygen flow
during exercise (84% of total). At the last follow-up
visit, 24.9% of 1309 patients showed the PaO2
greater than 8 kPa at rest whilst breathing air and
40.4% of 1288 patients had the oxyhemoglobin
saturation greater than 89%. The original pre-
scribed flow of oxygen had in the course of time
been modified in 52% of patients. The prescription
had been modified on the basis of the arterial blood
gases analysis (BGA) in 94% of cases; in 56% only the
BGA had been carried out; in 38% BGA and pulse
oxymetry had been performed. In eight cases (out
of a total of 745 responses) the prescription had
been modified solely on the basis of the clinical
examination.
Twenty-one per cent of patients reported to
practice oxygen therapy for less than 15 h/day.
Evaluating the variables related to the group of
patients that claimed to practice a daily length of
oxygen therapy o15 h, when they had a greater
length of oxygen prescription by the physician, we
did not find any impact of age, gender, duration of
LTOT introduction, respiratory diagnosis and degree
of instruction. On the contrary, the PaO2 greater
than 8 kPa at the last follow-up visit was associated
to less compliance (12% vs. 16%; Po0:05), as well as
a greater flow of oxygen at rest (w2 test for trend
Po0:001). Patients reported using oxygen for less
hours than had been prescribed by the physician
both at rest during the day (P ¼ 0:02, k ¼ 0:80) and
the night (P ¼ 0:0036, k ¼ 0:77), as well as during
exercise (P ¼ 0:002, k ¼ 0:72). Particularly, we
found a good relationship between the flow of
oxygen prescribed at rest during the day by the
physician and that known and reported by the
patient (NS, sign rank and 0.83 at the Cohen test),
as well as the flow prescribed in the night during
sleep by the physician and that known and reportedhe physician according to the respiratory diagnosis.
Indication to vary oxygen flow in the various
situations of everyday life (% of responses)
41
56
54
69
32
53
24
13
12
ARTICLE IN PRESS
Table 6 Main reasons causing the use of the
stroller less than prescribed.
Heavy Not
useful
I forget Uncomfortable Shame
26% 11% 6% 20% 37%
Table 5 Details of the oxygen flow prescribed by the physician in the various situations of everyday life.
Oxygen prescription
(L/min)
Percentage of responses at
rest
Percentage of responses in
the night
Percentage of responses
during exercise
o1 5.3 6.1 1.9
1 27.3 31.5 15.6
1.5 29.3 28.7 18.7
2 25.9 22.0 29.9
2.5 4.5 3.9 9.9
3 4.3 4.3 12.9
43 3.4 3.5 11.1
Table 7 Source of information on the correct use
of oxygen.
Figure Percentage of
responses
Pulmonologist 79
Nurse 27
Respiratory therapist 8
General practitioner 7
Commercial technician who
delivers oxygen
34
Pharmacist 2
Others 2
Nobody 2
The total percentage is more than 100% because more
than 1 answer was allowed.
Table 8 Did you perceive an improvement after
starting oxygen use?
No Immediately After some
days
After
weeks
12% 52% 19% 16%
Long-term oxygen therapy in chronic respiratory failure 799by the patient (NS, with k ¼ 0:82). On the contrary,
we found a marked discrepancy between the flow
prescribed by the physician during exercise and
that known and reported by the patient
(Po0:00003 with k ¼ 0:78). Patients reported using
the flow that they knew had been prescribed by the
physician both at rest during the day (NS; P ¼ 0:1)
and during exercise (NS; P ¼ 0:1), but at a lower
level (P ¼ 0:008) in the night. Of the 1232 patients
(84%) possessing a rechargeable portable device,
only 992 responded to the questions on its use: 47%
reported recharging it daily, 17% twice weekly, 10%
seldom, 26% only when they go outside for many
hours. However, only 41% reported using the
stroller always when outside the house. As Table 6
shows, a large number of patients either did not
respond to this question or said that they were
ashamed of being seen by passers-by with the
portable device.
Ninety-six per cent of patients had made
scheduled periodical control in the referring
centre; of these, 24% reported monthly visits, 65%
at intervals from 2 to 4 months. However, 66% of
patients had made at least one unscheduled visit
for respiratory problems and 9% had made up to five
in the course of the last year.
As Table 7 shows, only 2% of patients claimed
they had not received any information on the
correct use of oxygen. The great majority of those
who had received information (79% of cases)
said they had received it from a respiratory
specialist.Only 12% of patients reported that they did not
perceive a subjective improvement with oxygen
use; most patients reported that they perceived a
subjective improvement immediately after com-
mencing use (Table 8). Those who did not notice
any improvement after oxygen use tended to use
oxygen less time than prescribed (65720SDmin.
less than prescribed), but the difference was not
significant (Po0:065) compared to those who found
an improvement (and who did 2976min SD less than
prescribed). The perception of an improvement
probably constituted a stimulus to correct use. On
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knowledge about the rationale for oxygen therapy,
the correct response was the most frequent one:
‘‘they gave me oxygen because I have little in the
blood’’ (51%); nevertheless it remains of concern
that 48.5% did not give this answer; of these, 38.5%
said instead generically that ‘‘it was on account of
dyspnea’’.Discussion
In Italy there are approximately 50,000 patients on
domiciliary LTOT, but, except for a few regions,
precise numerical data are lacking. The National
Health Service fully covers expenses of LTOT.
LTOT prescription, in terms of the norms govern-
ing its use (e.g. professional competence for
prescription required, modalities), is quite homo-
geneous in all regions of Italy. A pulmonary
specialist of the National Health Service usually
effectuates LTOT prescription; anaesthetists or
paediatricians seldom prescribe LTOT, but only in
exceptional cases can other specialists do so. Our
study confirms this view: respiratory specialists
catered for 94% of LTOT prescriptions. Another
peculiarity, confirmed by our survey, is the wide-
scale use of liquid oxygen, even for elderly
patients.
The questions on LTOT prescribed by the physi-
cian highlight some problems. We observed that a
significant proportion of patients received the LTOT
prescription for respiratory failure not derived from
COPD. However, even if the benefits of LTOT in
terms of survival have been documented only for
COPD patients, it is common practice to use LTOT
for chronic respiratory failure from any cause. A
significant number of our patients (15%) received
the prescription for oxygen use of less than 15 h/
day. Another consistent group (25%) had the basal
PaO2 higher than 8 kPa at the last follow-up visit.
These data are cause of concern because they do
not correspond to evidence-based recommenda-
tions for good clinical practice.1 Moreover, various
studies have documented similar situations. In
France11 and in Denmark,12 respectively, 18% and
11% of patients on LTOT had the PaO2 greater than
8 kPa at rest whilst breathing air. The greater
percentage in our survey may be due to the slightly
different inclusion criteria for LTOT prescription
between these countries.13 In another study carried
out in the UK,14 46% of patients with LTOT had
values greater than 90% with pulse oxymetry. In
France9 and in the Netherlands,6 respectively, 24%
and 35% of COPD patients on LTOT had a prescrip-tion for oxygen use less than 15 h/day. To keep
patients well oxygenated, patients frequently need
extra oxygen during sleep and exercise.15–20 Some
chest physicians recommend an increase of resting
oxygen flow by 1 l/min for sleep and exercise,
whereas others individualise flow rates with or
without specific testing of each patient.21 As liquid
oxygen is suitable to assure good mobility and most
patients in our survey were using liquid oxygen, we
were not surprising that most physicians increased
the oxygen flow on exercise. On the contrary, when
during the sleep a variation of the oxygen flow was
suggested, we often observed a reduction rather
than an increase.
On the part of patients we found a fair, though
not optimal, compliance to the physician’s pre-
scription. We, as others,5,6,9,22 found an association
between good compliance to the prescribed oxygen
therapy and severity of resting hypoxemia. How-
ever, in our study the compliance to oxygen therapy
was based on self-reported data. It is known that
patients tend to overestimate their oxygen
usage.12,22,23 In a Danish study, 13% of patients
reported to use oxygen less than 15 h/day, but an
objective evaluation showed that the effective
percentage was approximately of 35% of the
total.12 To our knowledge, no survey has evaluated
on how patients follow medical prescriptions on
oxygen flow in different situations. We found that
the indications supplied by the physician on oxygen
use concord reasonably well with what the patient
remembers except for physical exercise. Likewise,
patients knew what the physician had prescribed,
but in a significant proportion of cases did not
comply with this in reality. This was true mainly for
the oxygen flow in the night.
Portable oxygen therapy has been shown to
relieve breathlessness and increase exercise toler-
ance in selected patients.24–26 Our data confirm
that portable liquid oxygen is useful in hypoxaemic
patients to decrease breathlessness. A significant
number of our patients reported to use oxygen for
treating breathlessness. Kampelmacher et al.6
reported a similar percentage of patients claiming
that LTOT had been prescribed for reducing breath-
lessness. Likewise, to the question whether they
were using a mobile system supplying oxygen
outdoors, a large number of our patients either
did not respond or reported that they did not use it,
often because they were ashamed of being seen by
passers-by with the stroller. Other authors,6 mainly
using gas cylinders as mobile source, reported
shame as a common cause, which limited the use
of oxygen outdoors. In a very different reality with
most patients using gaseous oxygen or concentra-
tors, but, on the other hand, similarly to us, a low
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the house has been reported,5,9,12,27 particularly if
they had not received specific instructions in
regard.5 In another multicentre study including
159 COPD patients, only 60% of patients in the
group with portable sources used their mobile
system outdoors without any difference between
gaseous and liquid oxygen.8 Thus our survey
confirms the use of liquid oxygen does not auto-
matically assure a good adherence to the pre-
scribed treatment or the use of supplemental
oxygen outdoors. Probably whatever the type of
used oxygen source there is need to provide
repeated educational sessions to patients on LTOT
to extend hours of oxygen therapy outside the
house and obtain a good compliance. In fact,
although our patients felt that they had received
in-depth and exhaustive information concerning
oxygen therapy, their behaviour did not always
reflect what they have learnt.
We conclude that in Italy most patients on LTOT
used liquid oxygen. Patients felt they had improved
as a result of LTOTand were satisfied with the degree
of information concerning oxygen therapy. Adher-
ence to prescription was acceptable with a tendency
to undertreatment in terms of length of daily oxygen
therapy and, intentionally, of flow rate when breath-
ing oxygen during sleep and, non-intentionally, on
exercise. The use of liquid oxygen did not auto-
matically increase the adherence to the prescribed
treatment and the hours of oxygen therapy outside
the house. On the physicians’ side, we found that the
appropriateness of the prescriptions was good, but
the criteria utilised did not always correspond to
evidence-based recommendations.
Good LTOT practice requires a lot of work both by
means of self-assessment on the part of physicians
of their own mode of operating (periodic audits
under the guidance of an expert pulmonologist?)
and through a program of in-depth education of the
patient, patient’s relatives and also of the general
population, which must learn to accept as natural
the presence of people using portable devices.
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Page 1To be completed by the physician
Patient general information
1. Sex: Male Female
2. Age: Tensyyyyyyy
Units yyyyyyy
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M. Neri et al.8023. Marital status: Married Never married
Widowed Separated/divorced4. Educational level: None Upper middle school
Elementary school University
Lower middle school5. Patient: Has made previous visits to the Centre taking part in the study
First-time visitorPatient’s disease
6. The patient’s disease is: (more than one answer possible)Chronic respiratory failure COPD
Diffuse interstitial lung disease TB sequelae
Bronchiectasis Kyphoscoliosis/other thoracic cage deformities
Neuromuscular diseases Apnea
Severe obesity Bronchopulmonary neoplasiaOtheryyyyyyyyyyyy
Ventilatory therapy
7. Is ventilatory support prescribed in association?
8. If a ventilator is used what type is it?
Volumetric
CPAP
Intermittent positive airway pressure
9. How many hours a day is the ventilator used?
Not every day yyyyyyyyyDiagnosis and prescription
10. Date of first diagnosis of respiratory failureLess than one year ago more than 5 years ago
From 1 to less than 2 years ago precise date unknown
From 2 to less than 5 years ago11. Date of first prescription of oxygen therapy
Less than 1 year ago more than 5 years ago
From 1 to less than 2 years ago precise date unknown
From 2 to less than 5 years ago
12. Who first prescribed the oxygen therapy?
Local family doctor Intensive care specialist
Pneumologist Other specialist13. The latest prescription indicates how many hours of oxygen therapy per day
Oxygen flow
14. Is the oxygen flow unvaried throughout the whole day?Yes No15. If no, in which circumstances is the flow to be varied?
At night During exercise16. What is the prescribed O2 flow at rest in liters?
17. What is the prescribed O2 flow at night in liters?
18. What is the prescribed O2 flow during exercise in liters?
19. The prescription of oxygen therapy is through what form?Liquid oxygen Concentrator Gas canister
20. If liquid oxygen was prescribed was a portable device also supplied? Yes No
21. Oxygen is delivered through:mask Canula
nasal prongs By tracheostomy level
esthetic eyeglasses
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22. With respect to the original prescription have any changes in oxygen flow or time been prescribed?Yes No
23. If yes, these changes were made on the basis of: (more than one answer possible)Clinical examination Blood gases analysis
Pulse oximetry (oxyhemoglobin saturation)
24. FEV1 % pred.
Tens
Units
25. Last PaO2 evaluated in room air at rest in stable conditions in mmHg:
26. Last SpO2 evaluated in room air at rest in stable conditions in %:Page 2
To be completed by the patient
1. When were you first prescribed oxygen therapy?
Less than 1 year ago more than 5 years ago
From 1 to 2 years ago I don’t remember
From 2 to 5 years ago2. How many liters of oxygen were you prescribed?
At rest
At night
During exercise3. What is the total number of hours, on average, per day that you use oxygen?
Less than 8yyy4. How many liters of oxygen do you usually use?
At rest
At night
During exercise5. Who explained to you in detail how to use oxygen? (more than one answer possible)
Firm representative Physiotherapist Pharmacist
Family doctor Nurses Nobody
Medical specialist Other6. Why were you prescribed oxygen? (more than one answer possible)
I don’t know I have chronic bronchitis
I have emphysema I have little oxygen in the blood
I am short of breath Other7. How often on average do you change your nasal prongs (or mask, or canula)?
Every 2–3 months At least once a month
After more than 3 months When they break8. And the replacement part is usually:
Supplied by my ASL Bought at my own expense
Supplied by the firm Got from the hospital when I go for a
check-up9. Do you use a gurgler to humidify your oxygen?
Yes No10. If yes, do you use
Water from the tap Distilled or demineralised water ?11. The water for your humidifier:
I top it up as the level goes down
Periodically I change the whole tank
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M. Neri et al.80412. Do you have periodic visits and/or examinations to check up on your oxygen therapy?
Yes Noo
213. If yes, how often on average do you have such check-ups?
Once a month Once every 5–8 months
Once every 2 months Once a year or longer
Once every 3–4 months14. If yes, what check-up examinations do you do? (more than one answer possible)
Visit to the doctor Breath test
Arterial blood test to measure oxygen
Assessment of oxygen saturation without blood testNB: because of a print error, there is no question 1516. Do you have a portable oxygen device? Yes No
17. If yes, do you use it regularly? Yes No
18. How often do you fill up your portable device?Every day
Twice a week
Once in a while, only when I am out of the house for many hours
Rarely19. When you go out of the house do you use your portable device?
Always Sometimes
Hardly ever or never20. If you use your portable oxygen device, how many hours (filling it up to the top)
does the flow, normally prescribed for you, last?Less than 2 h From 2 to 5 h More than 5 h21. If you do not use your portable oxygen device, or use it less than you are supposed to, this
is because:It is too heavy I have little need of it I forget it
It complicates things It bothers me to be seen by others22. Do you know the name of the firm that supplies the oxygen?
No Yes (specify)yyyyy23. Since you began using oxygen:
I have not noticed any improvement in my health
I immediately noticed an improvement in my health
I had an improvement, but only after a few days
I had an improvement, but only after a few weeks
24. Since you have been using oxygen:
I can do physical exercise or move better than before
I have not noticed any difference
Things are worse than before
25. To which of the following categories do you belong?
Never smoked Ex-sm ker
Used to smoke and still do occasionally Current smoker26. If you are an ex-smoker, approximately how many years ago did you quit smoking?
Less than 1 year ago From 1 to 5 years ago More than 5 years ago27. If you smoke or used to smoke, how many cigarettes per day on average do or did you smoke?
Less than 10 From 10 to 20 More than a packet28. If you smoke or used to smoke, for how many years approximately?
Less than 10 From 10 to 25 From 5 to 40 More than 40
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Long-term oxygen therapy in chronic respiratory failure 80529. If you smoke or used to smoke, did someone advise you/prescribe to quit smoking? (more than one
answer possible)Firm representative Physiotherapist Pharmacist
Family doctor Nurses Nobody
Medical specialist Other30. Do you consider you received sufficiently detailed information on the correct use of oxygen therapy?
Yes, but I could have received more Yes No31. How many unscheduled visits for respiratory problems have you made to a doctor in the last 365 days?
None 1 2–3 4–5 More than 532. How many times has your catarrh increased in volume or worsened in appearance in the last 365 days?
Never 1 2–3 4–5 More than 533. How many times have you used an antibiotic for respiratory problems?
Never 1 2–3 4–5 More than 534. How many medicines, including aerosols, sprays, tablets, plasters and/or injections, have you taken per
day on average over the last 365 days?None 1–3 4–5 5–9 More than 10References
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